EORTC-22791-ROG

Phase III trial of twice daily fractions versus single daily fraction radiotherapy in oropharyngeal carcinoma
Trial StatusAll trial activities ended
DatesDate of activation: 15-Feb-80
Closed on : 15-Apr-87
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size300
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Radiation Oncology Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT